Subtitle
Proton Therapy for Head and Neck Cancer.
Subtitle
Proton Therapy for Head and Neck Cancer.
Proto therapy Time
May 2018
Executive summary
A systematic review by MSKCC summarized the published clinical research, and the authors believe that widespread adoption of proton therapy will elucidate the true value of proton beam therapy and give a greater understanding of the full risks and benefits of proton therapy in head and neck cancer.
Top cancer treatments
Related contents
Proton Therapy Publication
April 2024
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.
en
Proton Therapy Publication
March 2024
Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points.
en
Proton Therapy Publication
October 2023
Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma.
en
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
en
Proton Therapy Publication
January 2023
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
en
Proton Therapy Publication
February 2023
Acute radiation dermatitis among patients with nasopharyngeal carcinoma treated with proton beam therapy: Prognostic factors and treatment outcomes.
en
Proton Therapy Publication
February 2023
Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer.
en
Proton Therapy Publication
May 2023
Gross tumor volume margin and local control in p16-positive oropharynx cancer patients treated with intensity modulated proton therapy.
en
Proton Therapy Publication
January 2024
A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer.
en